Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH): Yatharth Hospital Share Price hits fresh 52-week high as stock rises 5.13% to Rs 1,020

Published: 28 August 2026 at 9:53 AM IST

Yatharth Hospital Share Price opened the session in focus after Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) climbed 5.13% to Rs 1,020 and set a fresh 52-week high of Rs 1,024.95. The company’s market capitalisation stands at Rs 9,302.53 crore, placing the move in a clearly visible large-cap-like valuation band within the Healthcare universe. The supplied data confirms the price event and the day’s range, but it does not establish a company-specific catalyst. For readers tracking Yatharth Hospital Share Price Today, the update is relevant because the stock has moved to its yearly high while also trading well above the latest close.

The latest Yatharth Hospital Share News is therefore best read as a verified market event first and a valuation discussion second. Univest is tracking the same move through its stock page, where investors can compare the current quote, market capitalisation and the broader company snapshot without relying on conjecture. In this Yatharth Hospital Stock News update, the focus is on what the numbers show, what they do not show and how the stock sits within the hospital services segment.

Yatharth Hospital Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,020
Previous Close	Rs 970.25
Today's Move	+Rs 49.75 (+5.13%)
Open	Rs 980
High	Rs 1,024.95
Low	Rs 980
Turnover	Rs 2.05 crore
Market Capitalisation	Rs 9,302.53 crore

Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) traded at Rs 1,020 versus the previous close of Rs 970.25, a rise of 5.13%. The stock opened at Rs 980, reached a high of Rs 1,024.95 and touched a low of Rs 980.

Yatharth Hospital Share Price Today reflects a session that began at Rs 980, held the day’s low at Rs 980, and advanced to Rs 1,024.95, which is also the fresh 52-week high. The stock closed the previous session at Rs 970.25, so the day’s change of Rs 49.75 translated into a 5.13% rise. That is a clean verified move from the supplied data, and it places YATHARTH in the list of 52 Week High Stocks for the day.

What matters for Yatharth Hospital Share Price is the spread between the latest close and the yearly high. With the current price at Rs 1,020 and the one-year peak at Rs 1,024.95, the stock finished just Rs 4.95, or 0.48%, below the session high. Turnover stood at Rs 2.05 crore, which is a factual traded-value figure for the day. The price action shows that the stock moved through its prior ceiling and held close to the top of the range by the close. That makes the latest Yatharth Hospital Share Price Update a clear event-led move for Stock Market Today watchers. The next section looks at how the company’s supplied financial metrics and valuation frame this move.

Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 9,302.53 crore
P/E Ratio	96.92x
P/B Ratio	5.67x
ROE	10.53%
ROCE	14.35%
EPS	Rs 10.01
Book Value Per Share	Rs 189.51
Dividend Yield	0%

Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) fundamental metrics show P/E 96.92x, P/B 5.67x, ROE 10.53%, ROCE 14.35%. These figures provide context only and are not a buy or sell signal.

Yatharth Hospital & Trauma Care Services Ltd. has a market capitalisation of Rs 9302.53 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 96.92x, P/B at 5.67x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.53% and ROCE of 14.35%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 10.01, book value per share of Rs 189.51, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 47.68x, median ROE of 12.88%, median ROCE of 15.34%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	96.92x
Benchmark Median P/E	47.68x
Benchmark Average P/E	122.77x
Benchmark P/E Range	7.92x to 1,563.88x
Company P/B Ratio	5.67x
Benchmark Median P/B	4.15x
Company ROE	10.53%
Benchmark Median ROE	12.88%
Company ROCE	14.35%
Benchmark Median ROCE	15.34%
Company Market Capitalisation	Rs 9,302.53 crore
Benchmark Median Market Cap	Rs 598.7 crore

Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) has a P/E ratio of 96.92x, which is above the benchmark median of 47.68x, a difference of +103.27%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) has a ROE of 10.53%, which is below the benchmark median of 12.88%, a difference of -18.25%. Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) has a ROCE of 14.35%, which is below the benchmark median of 15.34%, a difference of -6.45%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Thyrocare Technologies Ltd.	THYROCARE	9,633.48	52.56	14.72	29.05	38.3
Jupiter Life Line Hospitals Ltd.	JLHL	9,797.2	53.7	6.37	13.39	15.7
Healthcare Global Enterprises Ltd.	HCG	10,533.27	625.62	6.49	5.72	12.36
Metropolis Healthcare Ltd.	METROPOLIS	11,832.5	59.33	7.67	13.53	20.03
NEPHROCARE HEALTH SERV L	NEPHROPLUS	6,974.27	89.51	6.06	9.22	16.18

Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) has a P/E ratio of 96.92x compared with the displayed peer median of 59.33x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.53% compares with a peer median of 13.39% across the companies shown in the table. ROCE stood at 14.35% versus the displayed peer median of 16.18%, providing a capital-efficiency comparison. Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) has a market capitalisation of Rs 9,302.53 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Yatharth Hospital

• Yatharth Hospital Share Price rose 5.13% to Rs 1,020 and printed a fresh 52-week high of Rs 1,024.95.
• The previous close was Rs 970.25, so the day’s gain was Rs 49.75.
• Turnover for the session stood at Rs 2.05 crore.
• Market capitalisation is Rs 9,302.53 crore, with P/E at 96.92 and P/B at 5.67.
• In the same-industry benchmark of 61 companies, the stock’s P/E is above the median of 47.68 and its ROE of 10.53% is below the median of 12.88%.

About Yatharth Hospital

Yatharth Hospital & Trauma Care Services Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. The supplied company profile places YATHARTH within a listed healthcare services context, with market-cap, earnings and return metrics available for review in the same dataset. For readers following Yatharth Hospital Share Price, that classification is the most reliable starting point for further stock analysis on Univest. The company’s latest financial numbers and sector benchmark are therefore the key reference points in this article.

Track Yatharth Hospital Share Price on Univest

Use Yatharth Hospital & Trauma Care Services Ltd. (YATHARTH) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors tracking Yatharth Hospital Share Price Today can use Univest to follow the live share price, market capitalisation, 52-week levels, valuation ratios, shareholding pattern and company financials in one place. Univest also presents Yatharth Hospital Stock Analysis and Yatharth Hospital Latest News in a format designed for quick comparison across the Healthcare sector.

Frequently Asked Questions

Why did Yatharth Hospital Share Price rise today?

Ans. The supplied data confirms a 5.13% rise to Rs 1,020 and a fresh 52-week high of Rs 1,024.95. It does not establish a company-specific catalyst, so the move should be read as a verified price event.

What is Yatharth Hospital Share Price today?

Ans. Yatharth Hospital Share Price today is Rs 1,020. The stock moved from a previous close of Rs 970.25 and finished close to the session high, which was also the fresh yearly peak.

What is the fresh 52-week high for Yatharth Hospital?

Ans. The fresh 52-week high for Yatharth Hospital Share Price is Rs 1,024.95. The current price of Rs 1,020 means the stock ended just below that level by Rs 4.95. The stock moved 5.13% during the session.

What is the market capitalisation of Yatharth Hospital?

Ans. Yatharth Hospital Share Price is backed by a market capitalisation of Rs 9,302.53 crore. That places the company in a visibly meaningful size band within the Healthcare sector. The company operates in the Healthcare sector.

How expensive is Yatharth Hospital on earnings?

Ans. Yatharth Hospital Share Price is trading on a P/E of 96.92 and a P/B of 5.67. Against the same-industry median P/E of 47.68, the earnings multiple is higher than the benchmark median.

What do ROE and ROCE show for Yatharth Hospital?

Ans. Yatharth Hospital Share Price comes with ROE of 10.53% and ROCE of 14.35%. Both are below the same-industry benchmark medians of 12.88% and 15.34% respectively. ROE stands at 10.53%. ROCE stands at 14.35%.

How do Yatharth Hospital financials look in the latest data?

Ans. Yatharth Hospital Share Price is supported by revenue of Rs 3,926.54 crore in Jun 2026 and net profit of Rs 470.61 crore. The dataset also shows EPS of Rs 10.01 and book value of Rs 189.51.

How does Yatharth Hospital compare with peers?

Ans. Yatharth Hospital Share Price can be compared with Thyrocare, Jupiter Life Line Hospitals, Metropolis and NEPHROCARE. Its valuation and return metrics sit between different peer extremes, so the comparison is mixed.